Nkarta Therapeutics Competitors and Similar CompaniesClear all
Nkarta Therapeutics's competitors and similar companies include AsclepiX Therapeutics, Courier Therapeutics and OncoQR ML.
 Nkarta Therapeutics Nkarta Therapeutics is a biopharmaceutical company developing engineered natural killer (NK) cell therapies for the treatment of cancer. |  AsclepiX Therapeutics AsclepiX Therapeutics is a biopharmaceutical company which focuses on therapies based on a peptide platform. |  Courier Therapeutics Courier Therapeutics is a biotechnology company providing a cytotoxic-lymphocyte targeting therapy platform. | ||
Founding Date | Founding Date 2015 | Founding Date 2011 | Founding Date 2015 | Founding Date 2013 |
Type | Type Public | Type Private | Type Private | Type Private |
Tags | ||||
Locations | Locations South San Francisco, US HQ | Locations Baltimore, US HQ Jersey City, US | Locations Houston, US HQ Houston, US | Locations Wien, AT HQ Irenental, AT Wien, AT |
Employees | Employees 1594% decrease | Employees 7 | Employees 1 | Employees 3 |
Funding | ||||
Total funding raised | Total funding raised $ 125m | Total funding raised $ 40m | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
AsclepiX Therapeutics
HQ
Baltimore, US
Employees
7
AsclepiX Therapeutics is a biopharmaceutical company which focuses on therapies based on a peptide platform.
View companyCourier Therapeutics
HQ
Houston, US
Employees
1
Courier Therapeutics is a biotechnology company providing a cytotoxic-lymphocyte targeting therapy platform.
View company
OncoQR ML
HQ
Wien, AT
Employees
3
OncoQR ML is a biotech company that develops cancer immunotherapies.
View company